Not spending enough time in the two deep stages of sleep — slow-wave and rapid eye movement, or REM, sleep — may hasten the deterioration of parts of the brain associated with Alzheimer’s ...

Your loved one's treatments will depend on the type they have. Many older people fear that they have Alzheimer's disease because they can't find their eyeglasses or remember someone's name.

Susan Aaron was an active 74-year-old retiree with Alzheimer’s who was told she might experience extreme fatigue and terrible headaches if she tried a new drug from Eisai Co. that promised to ...

Randall Bateman, MD, Charles F and Joanne Knight Distinguished Professor of Neurology at WashU Medicine. A study of Roche's anti-amyloid drug gantenerumab has suggested that early treatment to ...

The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China, and Japan gave a green light to ...

Most of our school resources create Dementia Friends, which is an Alzheimer’s Society initiative changing the way people think, act and talk about dementia. There are already millions of Dementia ...

DiADeM is a tool to support GPs in diagnosing dementia for people living with advanced dementia in a care home setting. It has been developed by the Yorkshire and Humber Dementia Strategic Clinical ...

Mar. 31, 2025 — New research reveals that lower proportions of specific sleep stages are associated with reduced brain volume in regions vulnerable to the development of Alzheimer's disease over ...

Do you know a conference you think we should list? Let us know by sending us an email with the details to [email protected].

Current biomarkers of cognitive impairment in individuals with Alzheimer’s disease perform poorly. Now, a stronger predictor emerges.

Researchers have developed a new blood test that can detect Alzheimer's disease and monitor its progression by measuring specific tau protein fragments in the blood. The test identifies fragments ...